Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D'Erasmo

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
La Radiologia Medica|March 6, 2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography studyFederica Catapano, Nicola Galea, Giacomo Pambianchi, et al.
Atherosclerosis|March 8, 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?Daniele Tramontano, Laura D'Erasmo, Miriam Larouche, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2025
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN RegistryLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Journal of Clinical Lipidology|November 10, 2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosisAlessia Di Costanzo, Ilenia Minicocci, Laura D'Erasmo, et al.
Frontiers in Genetics|September 8, 2022
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide StudyLaura D'Erasmo, Antonina Giammanco, Patrizia Suppressa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 13, 2024
Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA)Patrizia Tarugi, Stefano Bertolini, Sebastiano Calandra, et al.
Atherosclerosis|February 6, 2026
The hidden burden of kidney damage in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Journal of the American Heart Association|April 23, 2021
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular EventsLaura D'Erasmo, Ilenia Minicocci, Alessia Di Costanzo, et al.
Biomedicines|December 23, 2020
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)Alessia Di Costanzo, Annalisa Ronca, Laura D'Erasmo, et al.
Journal of Clinical Lipidology|January 4, 2021
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in ItalyGianfranco Mitacchione, Marco Schiavone, Antonio Curnis, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
La Radiologia Medica|March 6, 2023
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography studyFederica Catapano, Nicola Galea, Giacomo Pambianchi, et al.
Atherosclerosis|March 8, 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?Daniele Tramontano, Laura D'Erasmo, Miriam Larouche, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2025
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN RegistryLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Journal of Clinical Lipidology|November 10, 2021
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosisAlessia Di Costanzo, Ilenia Minicocci, Laura D'Erasmo, et al.
Frontiers in Genetics|September 8, 2022
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide StudyLaura D'Erasmo, Antonina Giammanco, Patrizia Suppressa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 13, 2024
Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA)Patrizia Tarugi, Stefano Bertolini, Sebastiano Calandra, et al.
Atherosclerosis|February 6, 2026
The hidden burden of kidney damage in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Journal of the American Heart Association|April 23, 2021
Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular EventsLaura D'Erasmo, Ilenia Minicocci, Alessia Di Costanzo, et al.
Biomedicines|December 23, 2020
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)Alessia Di Costanzo, Annalisa Ronca, Laura D'Erasmo, et al.
Journal of Clinical Lipidology|January 4, 2021
Impact of prior statin use on clinical outcomes in COVID-19 patients: data from tertiary referral hospitals during COVID-19 pandemic in ItalyGianfranco Mitacchione, Marco Schiavone, Antonio Curnis, et al.
Pageof 8